Sort by
Refine Your Search
-
Listed
-
Country
-
Field
-
culture, reproduction, or lentiviral technology. Candidates with less than one year of postdoctoral experience are preferred. Starting salary is US$66,300 per year plus benefits. Highly motivated and
-
be considered if their experimental experience is sufficient. Strong knowledge and experimental expertise of primary human tissue culture work including tissue explants and enteroids. Strong background
-
using cutting-edge proximity proteomics, protein engineering, CRISPR genome engineering, computational structural biology, and high-throughput electrophysiological techniques. The postdoc will engage in
-
, Electrical Engineering, Biomedical Engineering, Statistics, or a related field. Strong background in machine learning, data mining, statistical analysis, and computational modeling; Experience with programming
-
Postdoc in CRISPR Meta-Analytics and AI for Therapeutic Target Discovery and Priotisation (OT Grant)
(obtained at the call closure time or near completion) in a relevant subject, e.g., bioinformatics, computer science, mathematics, physics, engineering or a related field of science. Proven track record
-
cell and spatial RNA sequencing technology. Suitable candidate will acquire in vivo imaging and image analysis skills, collaborate on interdisciplinary projects with international collaborators, present
-
, Physics, Engineering, or a related field • Prior experience in modeling viral infections, bacterial infections, and/or immune response dynamics • Experience with parameter estimation techniques and data
-
Professor Ruijun Tian's team at Southern University of Science and Technology (SUSTech), Shenzhen, China has research interest on innovative proteomics technology development for mass spectrometry
-
, Biofunctional Food, Systems Biology, Food Chemistry and Technology, Food Quality, and Sensory and Consumer Science. The Department currently employs approx. 60 full time scientific staff and 50 PhD students and
-
cancer progression. We employ a diverse array of pre-clinical models including cancer cell lines, 3D spheroid cultures, orthotopic xenografts, patient-derived xenografts (PDXs), and genetically engineered